首页 | 本学科首页   官方微博 | 高级检索  
     

慢性肝病中抗肝抗原自身抗体的检测
引用本文:何文革,孙永涛,白雪帆,黄长形,聂青和,白宪光. 慢性肝病中抗肝抗原自身抗体的检测[J]. 胃肠病学和肝病学杂志, 2004, 13(2): 183-186
作者姓名:何文革  孙永涛  白雪帆  黄长形  聂青和  白宪光
作者单位:710038,西安,第四军医大学唐都医院全军感染病诊疗中心
摘    要:目的 探讨中国人不同病因所致慢性肝病患者中抗肝抗原自身抗体的存在状况及自身免疫性肝病的自身抗体特征。方法  166例肝功能异常患者分为 6组 :自身免疫性肝炎 (AIH ) 12例、原发性胆汁性肝硬化 (PBC) 2 0例、原发性硬化性胆管炎 (PSC)13例、HBV组 66例、HCV组 2 2例、肝豆状核变性 (HDL) 3 9例。用间接免疫荧光法检测抗核抗体 (ANA)、平滑肌抗体 (SMA)、抗肝肾微粒抗体I型抗体 (anti LKM1)、抗线粒体抗体 (AMA)和抗中性粒细胞胞浆抗体 (ANCA) ,免疫印迹法检测抗肝细胞胞溶质抗原 1型抗体 (anti_LC1)、抗可溶性肝抗原 /肝胰抗原抗体 (anti_SLA/LP)、抗肝肾微粒抗体 1型 (anti_LKM1)、AMA_M2亚型等多种肝抗原自身抗体。结果  166例中ANA、AMA、M_2、pANCA阳性率在 7组中有显著差异 (P <0 .0 1)。PBC中AMA、M 2阳性检出率均为 10 0 % ,PSC中pANCA阳性检出率为 5 3 8% ,Fisher精确检验在a =0 .0 0 2水准与其他各组比较有显著差异。AIH与PBC的ANA阳性率分别为10 0 %和 60 % ,Fisher精确检验在a =0 .0 0 2水准二者无显著差异。与其他各组比较有显著差异。在AIH组SMA阳性率为 2 5 % ,LKM 1、LC 1、SLA/LP阳性率均为 8.3 % ,统计学处理与其他组无显著差异 (P >0 0 5 ) ,可能与病例少有关。PBC中分别有 1

关 键 词:肝炎  肝硬化  胆管炎  肝豆状核变性  自身抗体
修稿时间:2003-11-15

Detection of autoantibodies to liver antigens in Chinese patients with different liver diseases
HE Wenge,SUN Yongtao,BAI Xuefan,et al Center of Diagnosis and Treatment for Infectious Diseases of PLA,Tangdu Hospital,No. Military Medical University,Xian ,China. Detection of autoantibodies to liver antigens in Chinese patients with different liver diseases[J]. Chinese Journal of Gastroenterology and Hepatology, 2004, 13(2): 183-186
Authors:HE Wenge  SUN Yongtao  BAI Xuefan  et al Center of Diagnosis  Treatment for Infectious Diseases of PLA  Tangdu Hospital  No. Military Medical University  Xian   China
Affiliation:HE Wenge,SUN Yongtao,BAI Xuefan,et al Center of Diagnosis and Treatment for Infectious Diseases of PLA,Tangdu Hospital,No.4 Military Medical University,Xian 710038,China
Abstract:Objective To study autoantibodies to liver antigens in Chinese patients with different liver diseases and to discuss the characteristics of autoantibodies in autoimmune liver diseases. Methods 166 patients with abnormal liver function were chosen and divided into 6 groups:(1) autoimmune hepatitis (AIH) group,12 cases;(2)primary biliary cirrhosis (PBC) group,20 cases;(3)primary sclerosing cholangitis (PSC) group,13 cases;(4)chronic hepatitis B(HBV) group,66 cases,(5)chronic hepatitis C(HCV)group,22 cases;(6)hepatolenticular degeneration (HDL) group,39 cases.20 healthy blood donors were control group.Antinuclear antibody (ANA),smooth muscle antibody (SMA),antimitochondrial antibody (AMA),antibody to liver/kidney micrososme type 1(anti-LKM1),perinuclear antineutrophil cytoplasmic antibody (pANCA) and cANCA were tested by indirect immunofluorescence.Then,anti-LKM1,antibody to liver cytosol type 1(anti-LC1),antibody to soluble liver antigen/liver-pancreas (anti-SLA/P) and subtype 2 of AMA (M-2) were detected by Western blot.Results AMA and M-2 positive were found in all PBC,and pANCA positive was found in 53.8% of PSC.ANA positive were found in all AIH and 60% of PBC.But there was no significant difference between them.In AIH group,SMA positive had been detected in 25% of patients.In additional,anti-LKM1 anti-LC1 and anti-SLA/LP were positive in 8.3% of AIH,respectively. Autoimmune overlap syndrome was found in 2 cases (AIH/PBC) with PBC,1 case (PSC/AIH) with PSC and 1 case (PBC/AIH) with AIH.However,few autoantibodies to liver antigens were found in non-autoimmune liver diseases group.Conclusion The detection for autoantibodies to liver antigens,ANA and subtype 2 of AMA are helpful for diagnosis and differential diagnosis for autoimmune live diseases.
Keywords:Hepatitis  Liver cirrhosis  Cholangitis  Hepatolenticular degeneration  Autoantibodies
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号